Last edition
News about "KBI Biopharma"
KBI Biopharma Signs Manufacturing Contract with Alanis Therapeutics
As part of this collaborative agreement, KBI will oversee cell line development, process optimization, analytical and formulation development, and the manufacturing of Alanis’ pre-clinical antagonistic antibody (mAb).
KBI Biopharma | 04/12/2024 | By Aishwarya
Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes
KBI Biopharma | 08/06/2023 | By Sudeep Soparkar | 276
KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility
The license allows KBI to fully support clients in their next phases of growth and certifies KBI's manufacturing capabilities in a cGMP environment
KBI Biopharma | 26/12/2022 | By Sudeep Soparkar | 420
KBI Biopharma, Selexis open expanded facility in Geneva, Switzerland
The ~94,000 square-foot facility will house new laboratories to support Selexis’ unique technical cell line workflows and KBI’s process development and cGMP manufacturing
KBI Biopharma | 11/07/2022 | By Sudeep Soparkar | 557
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy